scholarly article | Q13442814 |
P50 | author | Steven Libutti | Q7614982 |
Jorge A. Carrasquillo | Q40015819 | ||
Raymond M Reilly | Q89349001 | ||
David L Bartlett | Q97424233 | ||
Deborah A Scollard | Q107786878 | ||
H. Richard Alexander | Q123195986 | ||
P2093 | author name string | Hui Xu | |
Hui Deng | |||
J Andrea McCart | |||
Nan Tang | |||
Marshall Miller | |||
Navneet Mehta | |||
P2860 | cites work | Optical imaging of Renilla luciferase reporter gene expression in living mice | Q33897818 |
Positron-emission tomography reporter gene expression imaging in rat myocardium | Q34077922 | ||
Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours | Q34117185 | ||
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives | Q34390584 | ||
Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide | Q34608875 | ||
Positron emission tomography: measurement of transgene expression | Q34786910 | ||
Deletion of the vaccinia virus growth factor gene reduces virus virulence | Q36876074 | ||
Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography | Q37182575 | ||
Vaccinia virus: a tool for research and vaccine development | Q37755852 | ||
GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo | Q40565555 | ||
Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope-tagged receptor as a reporter | Q40672503 | ||
Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice | Q40733317 | ||
Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction | Q40775840 | ||
Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer | Q40957517 | ||
Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors | Q41675285 | ||
Structure of vaccinia virus late promoters | Q43610128 | ||
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression | Q43730024 | ||
A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts | Q43738447 | ||
Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging | Q43787639 | ||
Quantitative imaging of gene induction in living animals | Q43796870 | ||
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. | Q43873872 | ||
Optical imaging of cardiac reporter gene expression in living rats | Q43952376 | ||
In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus | Q43993914 | ||
In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas | Q44096379 | ||
In vivo quantitative noninvasive imaging of gene transfer by single-photon emission computerized tomography. | Q44363533 | ||
Imaging transgene expression in live animals | Q45198958 | ||
Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy | Q45750482 | ||
Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene | Q45855760 | ||
Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals | Q45862535 | ||
Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression | Q45869616 | ||
Noninvasive fluorescent imaging reliably estimates biomass in vivo | Q78721635 | ||
P433 | issue | 3 | |
P921 | main subject | oncolytic virus | Q1560099 |
Vaccinia virus | Q1986297 | ||
P304 | page(s) | 553-561 | |
P577 | publication date | 2004-09-01 | |
P1433 | published in | Molecular Therapy | Q15762400 |
P1476 | title | Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide | |
P478 | volume | 10 |
Q35285695 | A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma |
Q40176322 | A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus |
Q36391900 | A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication |
Q38924539 | Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses |
Q35591435 | First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity |
Q38673968 | Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery |
Q33887850 | Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene |
Q21245462 | Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus |
Q24628227 | Intelligent design: combination therapy with oncolytic viruses |
Q34212910 | Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans |
Q97537657 | Modeling oncolytic virus dynamics in the tumor microenvironment using zebrafish |
Q26999406 | Molecular imaging of oncolytic viral therapy |
Q34309856 | Multimodality imaging of gene transfer with a receptor-based reporter gene |
Q35234349 | Oncolytic Poxviruses |
Q39005715 | Oncolytic vaccinia virus as an adjuvant treatment to cytoreductive surgery for malignant peritoneal mesothelioma. |
Q37845399 | Oncolytic vaccinia virus for the treatment of cancer |
Q40907752 | Oncolytic vaccinia virus synergizes with irinotecan in colorectal cancer |
Q34287746 | Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene |
Q28069358 | Oncolytic virotherapy for pediatric malignancies: future prospects |
Q45324119 | Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect |
Q28237434 | Poxvirus tropism |
Q35292546 | Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β |
Q37779934 | Radiolabeled antiviral drugs and antibodies as virus-specific imaging probes |
Q34511795 | SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model |
Q35296661 | Somatostatin receptor based imaging and radionuclide therapy |
Q55379548 | Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions. |
Q37784291 | Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy |
Q33931616 | Synergistic interaction between oncolytic viruses augments tumor killing |
Q34909902 | Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer |
Q41919532 | Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses |
Q100438293 | The Oncolytic Virus in Cancer Diagnosis and Treatment |
Q52594999 | The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses. |
Q37884052 | The use of molecular imaging of gene expression by radiotracers in gene therapy |
Q39628429 | Theranostic potential of oncolytic vaccinia virus |
Q42280873 | Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis. |
Q26746915 | Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors |
Search more.